,22 In the context of rat insulinoma cells, deficient for Wfs1, ibudilast, a canonical PDE4 inhibitor and NCS1 binding drug, has been used as an efficient treatment to restore calcium homeostasis, cell viability, and glucose-stimulated insulin secretion.22 Here, NCS1 is linked to pancreatic insulinoma.